Intelligence Platform
Patents
Browse 3,501 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8648119
Controlled release immunomodulator compositions and methods for the treatment of otic diso
granted patentUS 8648105
Diarylthiohydantoin compounds
granted patentUS 8648059
Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic my
granted patentUS 8648112
Therapeutic uses of urolithins
granted patentUS 8642534
Proteins and polynucleotides of Vibrio cholerae
granted patentUS 8642604
Substituted pyrazolo[3,2-d]pyrimidines as anti-cancer agents
granted patentUS 8642561
Peptides whose uptake by cells is controllable
granted patentUS 8642788
Activators of executioner procaspases 3, 6 and 7
granted patentUS 8642282
Inhibitors of nitric oxide synthase for treatment of melanoma
granted patentUS 8637011
Modulation of NKG2D
granted patentUS 8637470
Small humanin-like peptides
granted patentUS 8637565
Salinosporamides and methods for use thereof
granted patentUS 8624032
Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions
granted patentUS 8618096
Prodrug compositions and methods for using the same in treating cancer and malaria
granted patentUS 8617815
Molecules with effects on cellular development and function
granted patentUS 8617557
Antibody fusion with IL-12 proteins with disrupted heparin-binding activity
granted patentUS 8617143
Therapeutic agent delivery systems and devices
granted patentUS 8613900
Nanostructured transition metal oxides useful for water oxidation catalysis
granted patentUS 8609417
Methods and compositions for stem cell cultures
granted patentUS 8609661
Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance
granted patentUS 8609608
Antimicrobial peptides
granted patentUS 8609334
Biomarkers for painful intervertebral discs and methods of use thereof
granted patentUS 8609843
Photoactive metal nitrosyls for blood pressure regulation and cancer therapy
granted patentUS 8603543
Mesocellular oxide foams as hemostatic compositions and methods of use
granted